Al-Riyami Lamyaa, Rodgers David T, Rzepecka Justyna, Pineda Miguel A, Suckling Colin J, Harnett Margaret M, Harnett William
Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK.
Exp Parasitol. 2015 Nov;158:18-22. doi: 10.1016/j.exppara.2015.03.025. Epub 2015 Mar 30.
ES-62 is the major secreted protein of the rodent filarial nematode Acanthocheilonema viteae. The molecule contains covalently attached phosphorylcholine (PC) residues, which confer anti-inflammatory properties on ES-62, underpinning the idea that drugs based on this active moiety may have therapeutic potential in human diseases associated with aberrant inflammation. Here we demonstrate that two synthetic small molecule analogues (SMAs) of ES-62 termed SMA 11a and SMA 12b are protective in the oxazolone-induced acute allergic contact dermatitis mouse model of skin inflammation, as measured by a significant reduction in ear inflammation following their administration before oxazolone sensitisation and before oxazolone challenge. Furthermore, it was found that when tested, 12b was effective at reducing ear swelling even when first administered before challenge. Histological analysis of the ears showed elevated cellular infiltration and collagen deposition in oxazolone-treated mice both of which were reduced by treatment with the two SMAs. Likewise, the oxazolone-induced increase in IFNγ mRNA in the ears was reduced but no effect on other cytokines investigated was observed. Finally, no influence on the mast cell populations in the ear was observed.
ES-62是啮齿类丝虫线虫棘唇旋尾线虫分泌的主要蛋白质。该分子含有共价连接的磷酸胆碱(PC)残基,赋予ES-62抗炎特性,这支持了基于该活性部分的药物可能对与异常炎症相关的人类疾病具有治疗潜力的观点。在此,我们证明了ES-62的两种合成小分子类似物(SMA),即SMA 11a和SMA 12b,在恶唑酮诱导的皮肤炎症急性过敏性接触性皮炎小鼠模型中具有保护作用,在恶唑酮致敏前和恶唑酮激发前给药后,耳部炎症显著减轻,以此作为衡量标准。此外,研究发现,在激发前首次给药时,12b在减轻耳部肿胀方面也有效。耳部组织学分析显示,恶唑酮处理的小鼠耳部细胞浸润和胶原蛋白沉积增加,而两种SMA处理可使其减少。同样,恶唑酮诱导的耳部IFNγ mRNA增加也减少,但未观察到对所研究的其他细胞因子有影响。最后,未观察到对耳部肥大细胞群体有影响。